Asia Spotlight 2014 Big Pharma China Growth: The Winner Is…
Executive Summary
Despite turbulence in China, multinational drug makers grew on average by 12% in the year, with sales at some increasing by more than 20%. A review of earnings updates identifies the winners, fastest improvers and laggards.